Evrofarma SA announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 15.144 million compared to EUR 13.559 million a year ago. Net income was EUR 660,000 compared to EUR 338,000 a year ago. Basic earnings per share from continuing operations was EUR 0.048 compared to EUR 0.025 a year ago. Diluted earnings per share from continuing operations was EUR 0.0483 compared to EUR 0.0247 a year ago.